Epistaxis after sildenafil [6]

Journal of the Royal Society of Medicine

Volumn 95, Issue 10, 2002, Pages 528-

  Bott, Simon R J ^a   Shergill, Iqbal ^a   Arya, Manit ^a  

^a INSTITUTE OF UROLOGY AND NEPHROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; PHOSPHODIESTERASE INHIBITOR; SILDENAFIL; CGMP BINDING, CGMP SPECIFIC 3',5' CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CGMP-BINDING, CGMP-SPECIFIC 3',5'-CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; CYCLIC GMP PHOSPHODIESTERASE; PHOSPHODIESTERASE; PIPERAZINE DERIVATIVE; VASODILATOR AGENT;

BRAIN HEMORRHAGE; CASE REPORT; DRUG INDUCED DISEASE; DRUG METABOLISM; EPISTAXIS; ERECTILE DYSFUNCTION; ESOPHAGUS VARICES BLEEDING; FLUSHING; HEADACHE; HUMAN; HYPOTENSION; LETTER; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; RECTUM HEMORRHAGE; THROMBOCYTE AGGREGATION INHIBITION; TREATMENT OUTCOME; VERTIGO; CHEMICALLY INDUCED DISORDER; MALE; NOTE; PHYSIOLOGY;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; EPISTAXIS; HUMANS; MALE; PHOSPHODIESTERASE INHIBITORS; PHOSPHORIC DIESTER HYDROLASES; PIPERAZINES; VASODILATOR AGENTS;

EID: 0036795564     PISSN: 01410768     EISSN: None     Source Type: Journal    
DOI: 10.1258/jrsm.95.10.528     Document Type: Letter

References (5)

1. Hicklin LA, Ryan C, Wong DKK, Hinton AE. Nose-bleeds after sildenafil (Viagra). J R Soc Med 2002;95:402-3
2. Morales A, Gingell C, Collins M et al. Clinical safety of oral sildenafil citrate (VIAGRA®) in the treatment of erectile dysfunction. Int J Impot Res 1998;10:69-74
3. Berkels R, Klotz T, Sticht G, Englemann U, Klaus W. Modulation of human platelet aggregation by the phosphodiesterase type 5 inhibitor sildenafil. J Cardiovasc Pharmacol 2001;37:413-21
4. Tzathas C, Christidou A, Ladas SD. Sildenafil (Viagra) is a risk factor for acute variceal bleeding. Am J Gastroenterol 2002;97:1856
5. Sheikh AR, Yasmeen S, Prindiville TP. Hemorrhoidal bleeding associated with sildenafil. Am J Gastroenterol 2001;96:2518-19